Union Park Capital

Union Park Capital is a private equity investment firm focused on lower middle-market industrial technology companies rather than a biotech, pharma, or healthcare operating company. The firm partners with management teams to grow businesses through organic initiatives and strategic add-on acquisitions, emphasizing long-term value creation over financial engineering. Its portfolio includes industrial and instrumentation-related businesses spanning environmental intelligence, food quality and safety instrumentation, process analytics, motion control, and related technical markets. For a biotech analyst, the key point is that Union Park Capital is an investor and owner of industrial technology assets, not a drug developer with a therapeutic pipeline.